OPK

Opko Health, Inc.

0.97 USD
-0.00 (-0.01%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Opko Health, Inc. stock is down -3% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.83% of the previous 28 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 10 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
08 Jan 19:20 20 Dec, 2024 1.00 CALL 1660 25150
08 Jan 19:27 20 Dec, 2024 1.00 CALL 1271 25150
08 Jan 19:27 20 Dec, 2024 1.00 CALL 2331 25150
08 Jan 20:15 15 Mar, 2024 1.00 CALL 2500 6357
08 Jan 20:16 20 Dec, 2024 1.00 CALL 1227 25150
08 Jan 20:24 20 Dec, 2024 1.00 CALL 6904 25150
08 Jan 20:27 20 Dec, 2024 1.00 CALL 888 25150
08 Jan 20:27 20 Dec, 2024 1.00 CALL 2946 25150
11 Jan 15:16 20 Dec, 2024 1.00 CALL 4674 52908
31 Jan 15:42 20 Dec, 2024 1.00 CALL 888 58892

About Opko Health, Inc.

OPKO Health, Inc. engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency.